Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.
Heart Fail Clin. 2019 Jan;15(1):19-27
Authors: Mentzer G, Hsich EM
There are millions of people affected by heart failure with reduced ejection fraction (HFrEF) as diagnosed with ejection fraction 40% or less by imaging. Established therapies have been proven through clinical trials on lifestyle interventions, medications, and devices for HFrEF to improve quality of life, heart function, and survival. Although there are more men than women suffering with HFrEF, there are no prospectively proven, sex-specific guideline therapies because women have been underrepresented in clinical trials. Current recommendations for medications in women with HFrEF are described in this article.
PMID: 30449377 [PubMed - in process]